Pancreatic Cancer Research

ResearcherHammoud Hospital University Medical CenterNo recent work listed

Fadi Farhat

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-8594-1701; OpenAlex author ID A5101969558. Sources: OpenAlex.

Their work

Papers
2 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
8
Papers, trials and grants by year

2016: 1 paper · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: 1 paper

Papers 2

  1. Neo-adjuvant FOLFIRINOX in borderline resectable and locally advanced pancreatic adenocarcinoma. Co-author DOI 10.1111/ajco.13775↗
  2. EARLY INCREASE of CA 19-9 in ADVANCED PANCREATIC CANCER RECEIVING FOLFIRINOX. Is it a sign of efficacy?. Last author DOI 10.12816/0027466↗

Closest collaborators

The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Haifa Dbouk · 1 shared paper, 2022 · strength 0.14
  2. Walid Ghazi Faraj · 1 shared paper, 2022 · strength 0.14
  3. Ghassan K. Abou‐Alfa · 1 shared paper, 2022 · strength 0.14
  4. Eileen Mary O'Reilly · 1 shared paper, 2022 · strength 0.14
  5. Sally Naji Temraz · 1 shared paper, 2022 · strength 0.14
  6. Ali I. Shamseddine · 1 shared paper, 2022 · strength 0.14
  7. Samer Tabch · 1 shared paper, 2016 · strength 0.10
  8. Hampig Raphaël Kourié · 1 shared paper, 2016 · strength 0.10

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.